S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   4481
 
                        2019-2020 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 4, 2019
                                ___________
 
 Introduced  by M. of A. CUSICK, ORTIZ, ABBATE, SCHIMMINGER, ENGLEBRIGHT,
   PERRY, OTIS -- Multi-Sponsored by -- M. of A. AUBRY, COLTON,  GUNTHER,
   LUPARDO,  PEOPLES-STOKES,  RIVERA  --  read  once  and referred to the
   Committee on Health
 
 AN ACT to amend the public health law, the tax law and the state finance
   law, in relation to providing for taxpayer gifts for leukemia, lympho-
   ma and myeloma research, education and treatment and establishing  the
   leukemia, lymphoma and myeloma research, education and treatment fund
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The public health law is amended by adding  a  new  article
 27-CCC to read as follows:
                              ARTICLE 27-CCC
 LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT PROGRAM
 SECTION 2747. LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH, EDUCATION AND
                 TREATMENT.
   § 2747. LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
 MENT.   THE COMMISSIONER SHALL ESTABLISH WITHIN THE DEPARTMENT A PROGRAM
 TO PROMOTE RESEARCH, EDUCATION AND TREATMENT REGARDING LEUKEMIA, LYMPHO-
 MA AND MYELOMA. TO CARRY OUT THE PURPOSES OF THIS SECTION,  THE  COMMIS-
 SIONER SHALL HAVE THE FOLLOWING POWERS AND DUTIES:
   1.  TO  PROMOTE RESEARCH, EDUCATION AND TREATMENT PROGRAMS DESIGNED TO
 REDUCE OR PREVENT THE INCIDENCE AND SEVERITY OF LEUKEMIA,  LYMPHOMA  AND
 MYELOMA;
   2. TO ACCEPT AND EXPEND ANY GRANTS, AWARDS OR OTHER FUNDS OR APPROPRI-
 ATIONS  AS MAY BE AVAILABLE FOR THESE PURPOSES SUBJECT TO LIMITATIONS AS
 TO THE APPROVAL OF EXPENDITURES AND AUDIT AS PRESCRIBED FOR STATE  FUNDS
 BY THE STATE FINANCE LAW; AND
   3.  TO  ENTER  INTO CONTRACTS WITHIN THE AMOUNTS AVAILABLE THEREFOR AS
 MAY BE NECESSARY TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD00108-01-9
              

 A. 4481                             2
 
   § 2. The tax law is amended by adding a new section 209-M to  read  as
 follows:
   §  209-M.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
 AND TREATMENT. EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER JANUARY
 FIRST, TWO THOUSAND TWENTY, A TAXPAYER IN ANY TAXABLE YEAR MAY ELECT  TO
 CONTRIBUTE  TO  THE  SUPPORT  OF  THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
 RESEARCH, EDUCATION AND TREATMENT FUND. SUCH CONTRIBUTION  SHALL  BE  IN
 ANY WHOLE DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF THE STATE TAX
 OWED  BY  SUCH  TAXPAYER.  THE  COMMISSIONER  SHALL INCLUDE SPACE ON THE
 CORPORATE INCOME TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIB-
 UTION.   NOTWITHSTANDING  ANY  OTHER  PROVISION  OF  LAW,  ALL  REVENUES
 COLLECTED PURSUANT TO THIS SECTION SHALL BE CREDITED  TO  THE  LEUKEMIA,
 LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND TREATMENT FUND AND SHALL BE
 USED  ONLY FOR THOSE PURPOSES ENUMERATED IN SECTION NINETY-SEVEN-SSSS OF
 THE STATE FINANCE LAW.
   § 3. The tax law is amended by adding a new section 630-g to  read  as
 follows:
   §  630-G.  GIFT FOR LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION
 AND TREATMENT.  EFFECTIVE FOR ANY TAX YEAR COMMENCING ON OR AFTER  JANU-
 ARY  FIRST,  TWO  THOUSAND TWENTY, AN INDIVIDUAL IN ANY TAXABLE YEAR MAY
 ELECT TO CONTRIBUTE TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA  RESEARCH,
 EDUCATION  AND  TREATMENT  FUND. SUCH CONTRIBUTION SHALL BE IN ANY WHOLE
 DOLLAR AMOUNT AND SHALL NOT REDUCE THE AMOUNT OF STATE TAX OWED BY  SUCH
 INDIVIDUAL.  THE COMMISSIONER SHALL INCLUDE SPACE ON THE PERSONAL INCOME
 TAX RETURN TO ENABLE A TAXPAYER TO MAKE  SUCH  CONTRIBUTION.    NOTWITH-
 STANDING  ANY  OTHER PROVISION OF LAW ALL REVENUES COLLECTED PURSUANT TO
 THIS SECTION SHALL BE CREDITED TO THE  LEUKEMIA,  LYMPHOMA  AND  MYELOMA
 RESEARCH,  EDUCATION AND TREATMENT FUND AND USED ONLY FOR THOSE PURPOSES
 ENUMERATED IN SECTION NINETY-SEVEN-SSSS OF THE STATE FINANCE LAW.
   § 4. The state finance law is amended by adding a new section  97-ssss
 to read as follows:
   §  97-SSSS.  LEUKEMIA,  LYMPHOMA  AND  MYELOMA RESEARCH, EDUCATION AND
 TREATMENT FUND. 1. THERE IS HEREBY ESTABLISHED IN THE JOINT  CUSTODY  OF
 THE  COMMISSIONER OF TAXATION AND FINANCE AND THE COMPTROLLER, A SPECIAL
 FUND TO BE KNOWN AS THE "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCA-
 TION AND TREATMENT FUND".
   2. SUCH FUND SHALL CONSIST OF ALL REVENUES RECEIVED BY THE  DEPARTMENT
 OF  TAXATION  AND  FINANCE,  PURSUANT  TO  THE PROVISIONS OF SECTION TWO
 HUNDRED NINE-M AND SECTION SIX HUNDRED THIRTY-G OF THE TAX LAW  AND  ALL
 OTHER  MONEYS  APPROPRIATED,  CREDITED,  OR TRANSFERRED THERETO FROM ANY
 OTHER FUND OR SOURCE PURSUANT TO LAW. NOTHING CONTAINED IN THIS  SECTION
 SHALL PREVENT THE STATE FROM RECEIVING GRANTS, GIFTS OR BEQUESTS FOR THE
 PURPOSES OF THE FUND AS DEFINED IN THIS SECTION AND DEPOSITING THEM INTO
 THE FUND ACCORDING TO LAW.
   2-A. ON OR BEFORE THE FIRST DAY OF FEBRUARY EACH YEAR, THE COMMISSION-
 ER  OF  HEALTH SHALL PROVIDE A WRITTEN REPORT TO THE TEMPORARY PRESIDENT
 OF THE SENATE, THE SPEAKER OF THE ASSEMBLY,  THE  CHAIR  OF  THE  SENATE
 FINANCE  COMMITTEE,  THE CHAIR OF THE ASSEMBLY WAYS AND MEANS COMMITTEE,
 THE CHAIR OF THE SENATE COMMITTEE ON HEALTH, THE CHAIR OF  THE  ASSEMBLY
 HEALTH  COMMITTEE,  THE  STATE  COMPTROLLER  AND THE PUBLIC. SUCH REPORT
 SHALL INCLUDE HOW THE MONIES  OF  THE  FUND  WERE  UTILIZED  DURING  THE
 PRECEDING CALENDAR YEAR, AND SHALL INCLUDE:
   (I)  THE AMOUNT OF MONEY DISPERSED FROM THE FUND AND THE AWARD PROCESS
 USED FOR SUCH DISBURSEMENTS;
   (II) RECIPIENTS OF AWARDS FROM THE FUND;
   (III) THE AMOUNT AWARDED TO EACH RECIPIENT;

 A. 4481                             3
 
   (IV) THE PURPOSES FOR WHICH SUCH AWARDS WERE GRANTED; AND
   (V) A SUMMARY FINANCIAL PLAN FOR SUCH MONIES WHICH SHALL INCLUDE ESTI-
 MATES OF ALL RECEIPTS AND ALL DISBURSEMENTS FOR THE CURRENT AND SUCCEED-
 ING  FISCAL  YEARS,  ALONG WITH THE ACTUAL RESULTS FROM THE PRIOR FISCAL
 YEAR.
   3. MONIES OF THE FUND SHALL BE EXPENDED ONLY  FOR  LEUKEMIA,  LYMPHOMA
 AND  MYELOMA RESEARCH, EDUCATION AND TREATMENT PROJECTS. AS USED IN THIS
 SECTION, "LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND  TREAT-
 MENT PROJECTS" MEANS RESEARCH, EDUCATION AND TREATMENT PROJECTS, INCLUD-
 ING  GRANTS  FOR  LEUKEMIA, LYMPHOMA AND MYELOMA RESEARCH, EDUCATION AND
 TREATMENT, WHICH, PURSUANT TO SECTION TWENTY-SEVEN  HUNDRED  FORTY-SEVEN
 OF  THE  PUBLIC  HEALTH  LAW,  ARE APPROVED BY THE DEPARTMENT OF HEALTH.
 SUCH GRANTS MAY INCLUDE, AMONG OTHERS,  GRANTS  TO  PUBLIC  AND  PRIVATE
 HOSPITALS, MEDICAL CENTERS, MEDICAL SCHOOLS AND OTHER ORGANIZATIONS.
   4.  MONIES  SHALL BE PAYABLE FROM THE FUND ON THE AUDIT AND WARRANT OF
 THE COMPTROLLER ON VOUCHERS APPROVED AND CERTIFIED BY  THE  COMMISSIONER
 OF HEALTH.
   5.  TO THE EXTENT PRACTICABLE, THE COMMISSIONER OF HEALTH SHALL ENSURE
 THAT ALL MONIES RECEIVED DURING A FISCAL YEAR ARE EXPENDED PRIOR TO  THE
 END OF THAT FISCAL YEAR.
   § 5. This act shall take effect immediately and shall apply to taxable
 years commencing on or after January 1, 2020.